HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amino acid-based compound activates atypical PKC and leptin receptor pathways to improve glycemia and anxiety like behavior in diabetic mice.

Abstract
Differences in glucose uptake in peripheral and neural tissues account for the reduced efficacy of insulin in nervous tissues. Herein, we report the design of short peptides, referred as amino acid compounds (AAC) with and without a modified side chain moiety. At nanomolar concentrations, a candidate therapeutic molecule, AAC2, containing a 7-(diethylamino) coumarin-3-carboxamide side-chain improved glucose control in human peripheral adipocytes and the endothelial brain barrier cells by activation of insulin-insensitive glucose transporter 1 (GLUT1). AAC2 interacted specifically with the leptin receptor (LepR) and activated atypical protein kinase C zeta (PKCς) to increase glucose uptake. The effects induced by AAC2 were absent in leptin receptor-deficient predipocytes and in Leprdb mice. In contrast, AAC2 established glycemic control altering food intake in leptin-deficient Lepob mice. Therefore, AAC2 activated the LepR and acted in a cytokine-like manner distinct from leptin. In a monogenic Ins2Akita mouse model for the phenotypes associated with type 1 diabetes, AAC2 rescued systemic glucose uptake in these mice without an increase in insulin levels and adiposity, as seen in insulin-treated Ins2Akita mice. In contrast to insulin, AAC2 treatment increased brain mass and reduced anxiety-related behavior in Ins2Akita mice. Our data suggests that the unique mechanism of action for AAC2, activating LepR/PKCς/GLUT1 axis, offers an effective strategy to broaden glycemic control for the prevention of diabetic complications of the nervous system and, possibly, other insulin insensitive or resistant tissues.
AuthorsAejin Lee, Yuan Sun, Tao Lin, No-Joon Song, McKensie L Mason, Jacob H Leung, Devan Kowdley, Jennifer Wall, Alessandro Brunetti, Julie Fitzgerald, Lisa A Baer, Kristin I Stanford, Joana Ortega-Anaya, Laisa Gomes-Dias, Bradley Needleman, Sabrena Noria, Zachary Weil, Joshua J Blakeslee, Rafael Jiménez-Flores, Jon R Parquette, Ouliana Ziouzenkova
JournalBiomaterials (Biomaterials) Vol. 239 Pg. 119839 (05 2020) ISSN: 1878-5905 [Electronic] Netherlands
PMID32065973 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2020 Elsevier Ltd. All rights reserved.
Chemical References
  • Amino Acids
  • Blood Glucose
  • Insulin
  • Receptors, Leptin
Topics
  • Amino Acids
  • Animals
  • Anxiety
  • Blood Glucose
  • Diabetes Mellitus, Experimental (drug therapy)
  • Insulin
  • Mice
  • Mice, Inbred C57BL
  • Receptors, Leptin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: